ストックスクリーナーアプリを入手
83.40
4.32%
3.56
前日終値:
$79.84
開ける：
$79.99
24時間の取引高:
253.66K
Relative Volume:
0.75
時価総額：
$1.21B
収益：
$1.80M
当期純損益:
$1.76B
株価収益率:
0.7028
EPS:
118.674
ネットキャッシュフロー:
$-149.23M
1週間 パフォーマンス:
+5.26%
1か月 パフォーマンス:
+121.99%
6か月 パフォーマンス:
+532.90%
1年 パフォーマンス:
+495.78%
1日の値動き範囲:
$79.05
$84.77
1週間の範囲:
$76.01
$85.75
52週間の値動き範囲:
$10.80
$86.64
Inhibrx Biosciences Inc Stock (INBX) Company Profile
名前
Inhibrx Biosciences Inc
セクター
電話
(858) 795-4220
住所
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA
INBX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INBX
Inhibrx Biosciences Inc
|
83.53 | 1.16B | 1.80M | 1.76B | -149.23M | 118.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.06 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
760.89 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
437.57 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
922.65 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
200.09 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Inhibrx Biosciences Inc Stock (INBX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-23 | 開始されました | JMP Securities | Mkt Perform |
| 2024-01-23 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-03-16 | 開始されました | SMBC Nikko | Outperform |
| 2021-09-21 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2020-09-14 | 開始されました | Credit Suisse | Outperform |
| 2020-09-14 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Inhibrx Biosciences Inc (INBX) 最新ニュース
Will Inhibrx Biosciences Inc. stock deliver shareholder value2025 Key Highlights & Free Real-Time Volume Trigger Notifications - newser.com
What high frequency data says about Inhibrx Biosciences Inc.2025 Market Sentiment & Risk Adjusted Buy and Sell Alerts - newser.com
How high can Inhibrx Biosciences Inc. stock go2025 Valuation Update & Risk Controlled Stock Pick Alerts - newser.com
Multi factor analysis applied to Inhibrx Biosciences Inc.Weekly Gains Report & Weekly Watchlist for Hot Stocks - newser.com
Inhibrx Biosciences Inc. stock daily chart insights2025 Technical Patterns & Free Community Supported Trade Ideas - newser.com
How to recover losses in Inhibrx Biosciences Inc. stock2025 Market Outlook & Safe Capital Growth Tips - newser.com
Inhibrx Biosciences stock rating maintained at Market Perform by Citizens - Investing.com South Africa
Is Inhibrx Biosciences Inc. stock a buy in volatile marketsWeekly Trend Recap & Verified Stock Trade Ideas - newser.com
Will Inhibrx Biosciences Inc. stock pay special dividendsJuly 2025 Recap & Fast Gain Swing Alerts - newser.com
Inhibrx Biosciences Inc (INBX) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Why Inhibrx Biosciences Inc. stock appeals to analystsJuly 2025 Price Swings & Daily Chart Pattern Signal Reports - newser.com
What Wall Street predicts for Inhibrx Biosciences Inc. stock priceQuarterly Trade Summary & Weekly Top Gainers Trade List - newser.com
Press Release: Inhibrx Reports Third Quarter 2025 Financial Results - 富途牛牛
Inhibrx Misses Estimates Even As New Cancer Drug Shows Promise - Finimize
Inhibrx Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Earnings Flash (INBX) Inhibrx Biosciences Posts Q3 Loss $2.28 a Share - MarketScreener
Inhibrx Biosciences' Q3 net loss widens, misses EPS estimates - MarketScreener
Inhibrx Biosciences, Inc. SEC 10-Q Report - TradingView
[8-K] Inhibrx Biosciences, Inc. Reports Material Event | INBX SEC FilingForm 8-K - Stock Titan
[10-Q] Inhibrx Biosciences, Inc. Quarterly Earnings Report | INBX SEC FilingForm 10-Q - Stock Titan
Inhibrx’s Phase 2 Study on INBRX-109: A Potential Breakthrough in Chondrosarcoma Treatment - MSN
Inhibrx supports CTOS2025 spotlight on chondrosarcoma - Traders Union
Behavioral Patterns of INBX and Institutional Flows - news.stocktradersdaily.com
What does recent volatility data suggest for Inhibrx Biosciences Inc.Quarterly Profit Review & Consistent Income Trade Ideas - newser.com
Is Inhibrx Biosciences Inc. stock resilient to inflationEarnings Overview Summary & Accurate Intraday Trading Signals - newser.com
Tick level data insight on Inhibrx Biosciences Inc. volatilityJuly 2025 Recap & AI Enhanced Trading Alerts - newser.com
Will Inhibrx Biosciences Inc. stock benefit from sector rotation2025 AllTime Highs & Free Daily Entry Point Trade Alerts - newser.com
Inhibrx Biosciences (INBX) Expected to Announce Earnings on Thursday - Defense World
Inhibrx Biosciences Inc (INBX) 財務データ
収益
当期純利益
現金流量
EPS
1.64%
0.70%
大文字化:
|
ボリューム (24 時間):